End of an Era
The UK’s medicines regulator releases new guidance for Brexit

As the Brexit transition period comes to a close, the MHRA has issued guidance for pharma companies (
“If we are to ensure uninterrupted supply for the NHS from January, the MHRA must continue to work closely with them on details related to individual medicines as well as on issues related to the Northern Ireland Protocol,” said Richard Torbett, Chief Executive of the Association of the British Pharmaceutical Industry, in a statement responding to the news (
- MHRA, “MHRA post-transition period information” (2020). Available at https://bit.ly/2QOfAzK.
- ABPI, “ABPI response to MHRA guidance for the end of the transition period” (2020). bit.ly/3lKt51m.
After finishing my degree, I envisioned a career in science communications. However, life took an unexpected turn and I ended up teaching abroad. Though the experience was amazing and I learned a great deal from it, I jumped at the opportunity to work for Texere. I'm excited to see where this new journey takes me!